Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Intrathecal B-cell activation in LGI1 antibody encephalitis.

Lehmann-Horn K, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, Geschwind MD, Wilson MR, Zamvil SS, von Büdingen HC.

Neurol Neuroimmunol Neuroinflamm. 2020 Feb 6;7(2). pii: e669. doi: 10.1212/NXI.0000000000000669. Print 2020 Mar.

2.

International multicenter examination of MOG antibody assays.

Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, Fryer JP, Mills J, Teegen B, Mindorf S, Ritter N, Krummrei U, Stöcker W, Eggert J, Flanagan EP, Ramberger M, Hegen H, Rostasy K, Berger T, Leite MI, Palace J, Irani SR, Dale RC, Probst C, Probst M, Brilot F, Pittock SJ, Waters P.

Neurol Neuroimmunol Neuroinflamm. 2020 Feb 5;7(2). pii: e674. doi: 10.1212/NXI.0000000000000674. Print 2020 Mar 5.

3.

Pathologic tearfulness after limbic encephalitis: A novel disorder and its neural basis.

Argyropoulos GPD, Moore L, Loane C, Roca-Fernandez A, Lage-Martinez C, Gurau O, Irani SR, Zeman A, Butler CR.

Neurology. 2020 Jan 24. pii: 10.1212/WNL.0000000000008934. doi: 10.1212/WNL.0000000000008934. [Epub ahead of print]

PMID:
31980582
4.

Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases.

Kim Y, Hyun JW, Woodhall MR, Oh YM, Lee JE, Jung JY, Kim SY, Lee MY, Kim SH, Kim W, Irani SR, Waters P, Choi K, Kim HJ.

Mult Scler Relat Disord. 2020 Jan 9;40:101939. doi: 10.1016/j.msard.2020.101939. [Epub ahead of print]

PMID:
31978673
5.

Human hippocampal CA3 damage disrupts both recent and remote episodic memories.

Miller TD, Chong TT, Aimola Davies AM, Johnson MR, Irani SR, Husain M, Ng TW, Jacob S, Maddison P, Kennard C, Gowland PA, Rosenthal CR.

Elife. 2020 Jan 24;9. pii: e41836. doi: 10.7554/eLife.41836.

6.

Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy.

Dubey D, Britton J, McKeon A, Gadoth A, Zekeridou A, Lopez Chiriboga SA, Devine M, Cerhan JH, Dunlay K, Sagen J, Ramberger M, Waters P, Irani SR, Pittock SJ.

Ann Neurol. 2020 Feb;87(2):313-323. doi: 10.1002/ana.25655. Epub 2019 Dec 14.

7.

Distinctive Magnetic Resonance Imaging Findings in IgLON5 Antibody Disease.

Chen H, Wu J, Irani SR.

JAMA Neurol. 2019 Nov 4:1-2. doi: 10.1001/jamaneurol.2019.3638. [Epub ahead of print] No abstract available.

PMID:
31682709
8.

The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis.

Ramanathan S, Al-Diwani A, Waters P, Irani SR.

J Neurol. 2019 Oct 26. doi: 10.1007/s00415-019-09590-9. [Epub ahead of print] Review.

PMID:
31655889
9.

Hippocampal epileptogenesis in autoimmune encephalitis.

Romoli M, Krashia P, Sen A, Franciotta D, Gastaldi M, Nobili A, Mancini A, Nardi Cesarini E, Nigro P, Tambasco N, Mercuri NB, Parnetti L, Di Filippo M, D'Amelio M, Irani SR, Costa C, Calabresi P.

Ann Clin Transl Neurol. 2019 Nov;6(11):2261-2269. doi: 10.1002/acn3.50919. Epub 2019 Oct 15.

10.

Glycine receptor autoantibodies disrupt inhibitory neurotransmission.

Crisp SJ, Dixon CL, Jacobson L, Chabrol E, Irani SR, Leite MI, Leschziner G, Slaght SJ, Vincent A, Kullmann DM.

Brain. 2019 Nov 1;142(11):3398-3410. doi: 10.1093/brain/awz297.

11.

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.

Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, Longoni G, Irani SR, Sun B, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

JAMA Neurol. 2019 Sep 23. doi: 10.1001/jamaneurol.2019.2940. [Epub ahead of print]

12.

PDE10A antibodies in autoimmune encephalitis: A possible marker of cancer immunotherapy?

Titulaer MJ, Irani SR, Lassmann H.

Neurology. 2019 Aug 20;93(8):327-328. doi: 10.1212/WNL.0000000000007965. Epub 2019 Jul 17. No abstract available.

PMID:
31315974
13.

Network-wide abnormalities explain memory variability in hippocampal amnesia.

Argyropoulos GP, Loane C, Roca-Fernandez A, Lage-Martinez C, Gurau O, Irani SR, Butler CR.

Elife. 2019 Jul 8;8. pii: e46156. doi: 10.7554/eLife.46156.

14.

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients.

Takata K, Stathopoulos P, Cao M, Mané-Damas M, Fichtner ML, Benotti ES, Jacobson L, Waters P, Irani SR, Martinez-Martinez P, Beeson D, Losen M, Vincent A, Nowak RJ, O'Connor KC.

JCI Insight. 2019 Jun 20;4(12). pii: 127167. doi: 10.1172/jci.insight.127167. eCollection 2019 Jun 20.

15.

Hippocampal network abnormalities explain amnesia after VGKCC-Ab related autoimmune limbic encephalitis.

Loane C, Argyropoulos GPD, Roca-Fernández A, Lage C, Sheerin F, Ahmed S, Zamboni G, Mackay C, Irani SR, Butler CR.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):965-974. doi: 10.1136/jnnp-2018-320168. Epub 2019 May 9.

16.

The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.

Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, Lennox BR, Okai D, Manohar SG, Irani SR.

Lancet Psychiatry. 2019 Mar;6(3):235-246. doi: 10.1016/S2215-0366(19)30001-X. Epub 2019 Feb 11.

17.

A multicenter comparison of MOG-IgG cell-based assays.

Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ.

Neurology. 2019 Mar 12;92(11):e1250-e1255. doi: 10.1212/WNL.0000000000007096. Epub 2019 Feb 6.

18.

Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study.

Gastaldi M, De Rosa A, Maestri M, Zardini E, Scaranzin S, Guida M, Borrelli P, Ferraro OE, Lampasona V, Furlan R, Irani SR, Waters P, Lang B, Vincent A, Marchioni E, Ricciardi R, Franciotta D.

Eur J Neurol. 2019 Jul;26(7):992-999. doi: 10.1111/ene.13922. Epub 2019 Mar 25.

19.

NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia.

Savage SA, Irani SR, Leite MI, Zeman AZ.

J Neuroimmunol. 2019 Feb 15;327:41-43. doi: 10.1016/j.jneuroim.2019.01.011. Epub 2019 Jan 22.

20.

The role of thymic tolerance in CNS autoimmune disease.

Handel AE, Irani SR, Holländer GA.

Nat Rev Neurol. 2018 Dec;14(12):723-734. doi: 10.1038/s41582-018-0095-7. Review.

PMID:
30451970
21.

The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.

Maddison P, Titulaer MJ, Verschuuren JJ, Gozzard P, Lang B, Irani SR, Sabater L, Graus F, Murray A, Chapman CJ.

J Neuroimmunol. 2019 Jan 15;326:14-18. doi: 10.1016/j.jneuroim.2018.11.003. Epub 2018 Nov 8.

22.

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis.

Jang Y, Lee ST, Bae JY, Kim TJ, Jun JS, Moon J, Jung KH, Park KI, Irani SR, Chu K, Lee SK.

J Neuroinflammation. 2018 Sep 25;15(1):279. doi: 10.1186/s12974-018-1314-2.

23.

Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.

Vincent A, Pettingill P, Pettingill R, Lang B, Birch R, Waters P, Irani SR, Buckley C, Watanabe O, Arimura K, Kiernan MC.

JAMA Neurol. 2018 Dec 1;75(12):1519-1527. doi: 10.1001/jamaneurol.2018.2681.

24.

Hippocampal Functional Dynamics Are Clinically Implicated in Autoimmune Encephalitis With Faciobrachial Dystonic Seizures.

Nantes JC, Thomas AG, Voets NL, Best JG, Rosenthal CR, Al-Diwani A, Irani SR, Stagg CJ.

Front Neurol. 2018 Sep 4;9:736. doi: 10.3389/fneur.2018.00736. eCollection 2018.

25.

Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies.

Xu M, Bennett DLH, Querol LA, Wu LJ, Irani SR, Watson JC, Pittock SJ, Klein CJ.

J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):177-188. doi: 10.1136/jnnp-2018-318556. Epub 2018 Sep 17. Review.

PMID:
30224548
26.

The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders.

Damato V, Balint B, Kienzler AK, Irani SR.

Mov Disord. 2018 Sep;33(9):1376-1389. doi: 10.1002/mds.27446. Epub 2018 Sep 14. Review.

27.

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience.

Kinsella JA, Irani SR, Hollingsworth R, O'Shaughnessy D, Kane P, Foster M, Schott JM, Lunn MP.

JRSM Open. 2018 Sep 3;9(9):2054270418793021. doi: 10.1177/2054270418793021. eCollection 2018 Sep.

28.

Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.

Berridge G, Menassa DA, Moloney T, Waters PJ, Welding I, Thomsen S, Zuberi S, Fischer R, Aricescu AR, Pike M, Dale RC, Kessler B, Vincent A, Lim M, Irani SR, Lang B.

Neurology. 2018 Aug 21;91(8):e714-e723. doi: 10.1212/WNL.0000000000006035. Epub 2018 Jul 25.

29.

The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study.

Varley JA, Webb AJS, Balint B, Fung VSC, Sethi KD, Tijssen MAJ, Lynch T, Mohammad SS, Britton F, Evans M, Hacohen Y, Lin JP, Nardocci N, Granata T, Dale RC, Lim MJ, Bhatia KP, Lang AE, Irani SR.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):724-726. doi: 10.1136/jnnp-2018-318584. Epub 2018 Jul 21. No abstract available.

30.

Antiglycine receptor antibody related disease: a case series and literature review.

Swayne A, Tjoa L, Broadley S, Dionisio S, Gillis D, Jacobson L, Woodhall MR, McNabb A, Schweitzer D, Tsang B, Vincent A, Irani SR, Wong R, Waters P, Blum S.

Eur J Neurol. 2018 Oct;25(10):1290-1298. doi: 10.1111/ene.13721. Epub 2018 Jul 21. Review.

31.

Distinct HLA associations of LGI1 and CASPR2-antibody diseases.

Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR.

Brain. 2018 Aug 1;141(8):2263-2271. doi: 10.1093/brain/awy109.

32.

Seronegative antibody-mediated neurology after immune checkpoint inhibitors.

Wilson R, Menassa DA, Davies AJ, Michael S, Hester J, Kuker W, Collins GP, Cossins J, Beeson D, Steven N, Maddison P, Rinaldi S, Jacob S, Irani SR.

Ann Clin Transl Neurol. 2018 Mar 25;5(5):640-645. doi: 10.1002/acn3.547. eCollection 2018 May.

33.

Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis.

Symmonds M, Moran CH, Leite MI, Buckley C, Irani SR, Stephan KE, Friston KJ, Moran RJ.

Brain. 2018 Jun 1;141(6):1691-1702. doi: 10.1093/brain/awy107.

34.

Pathogenic potential of antibodies to the GABAB receptor.

Nibber A, Mann EO, Pettingill P, Waters P, Irani SR, Kullmann DM, Vincent A, Lang B.

Epilepsia Open. 2017 Jul 19;2(3):355-359. doi: 10.1002/epi4.12067. eCollection 2017 Sep.

35.

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.

Hyun JW, Huh SY, Shin HJ, Woodhall M, Kim SH, Irani SR, Lee SH, Waters P, Kim HJ.

Mult Scler. 2019 Apr;25(4):585-590. doi: 10.1177/1352458518761186. Epub 2018 Mar 7.

36.

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.

Wilson R, Makuch M, Kienzler AK, Varley J, Taylor J, Woodhall M, Palace J, Leite MI, Waters P, Irani SR.

Brain. 2018 Apr 1;141(4):1063-1074. doi: 10.1093/brain/awy010.

37.

N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications.

Makuch M, Wilson R, Al-Diwani A, Varley J, Kienzler AK, Taylor J, Berretta A, Fowler D, Lennox B, Leite MI, Waters P, Irani SR.

Ann Neurol. 2018 Mar;83(3):553-561. doi: 10.1002/ana.25173.

38.

The importance of early immunotherapy in patients with faciobrachial dystonic seizures.

Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR; Faciobrachial Dystonic Seizures Study Group.

Brain. 2018 Feb 1;141(2):348-356. doi: 10.1093/brain/awx323.

39.

Bortezomib for Neuromyelitis Optica Spectrum Disorder: A New Therapeutic Option for the More Severe Forms?

Taylor J, Irani SR.

JAMA Neurol. 2018 Jan 1;75(1):129. doi: 10.1001/jamaneurol.2017.3454. No abstract available.

PMID:
29159373
40.

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.

Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):526-534. doi: 10.1136/jnnp-2017-315720. Epub 2017 Oct 21. Review.

41.

Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Balint B, Vincent A, Meinck HM, Irani SR, Bhatia KP.

Brain. 2018 Jan 1;141(1):13-36. doi: 10.1093/brain/awx189. Review.

42.

Psychosis: an autoimmune disease?

Al-Diwani AAJ, Pollak TA, Irani SR, Lennox BR.

Immunology. 2017 Nov;152(3):388-401. doi: 10.1111/imm.12795. Epub 2017 Aug 3. Review.

43.

Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.

Hyun JW, Woodhall MR, Kim SH, Jeong IH, Kong B, Kim G, Kim Y, Park MS, Irani SR, Waters P, Kim HJ.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):811-817. doi: 10.1136/jnnp-2017-315998. Epub 2017 Jul 6.

PMID:
28684532
44.

LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures.

Aurangzeb S, Symmonds M, Knight RK, Kennett R, Wehner T, Irani SR.

Seizure. 2017 Aug;50:14-17. doi: 10.1016/j.seizure.2017.05.017. Epub 2017 May 30.

45.

Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy.

Varley J, Taylor J, Irani SR.

Neuropharmacology. 2018 Apr;132:71-82. doi: 10.1016/j.neuropharm.2017.04.046. Epub 2017 May 3. Review.

46.

Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis.

Miller TD, Chong TT, Aimola Davies AM, Ng TWC, Johnson MR, Irani SR, Vincent A, Husain M, Jacob S, Maddison P, Kennard C, Gowland PA, Rosenthal CR.

Brain. 2017 May 1;140(5):1212-1219. doi: 10.1093/brain/awx070.

47.

G2A1B3AA receptor antibodies and their clinical associations.

Waters PJ, Irani SR.

Neurology. 2017 Mar 14;88(11):1010-1011. doi: 10.1212/WNL.0000000000003758. Epub 2017 Feb 15. No abstract available.

PMID:
28202698
48.

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.

Lang B, Makuch M, Moloney T, Dettmann I, Mindorf S, Probst C, Stoecker W, Buckley C, Newton CR, Leite MI, Maddison P, Komorowski L, Adcock J, Vincent A, Waters P, Irani SR.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):353-361. doi: 10.1136/jnnp-2016-314758. Epub 2017 Jan 23.

49.

The trouble with plasma cells: Getting to the root cause.

Rüegg S, Irani SR.

Neurology. 2017 Jan 24;88(4):340-341. doi: 10.1212/WNL.0000000000003545. Epub 2016 Dec 21. No abstract available.

PMID:
28003504
50.

Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions.

Bakpa OD, Reuber M, Irani SR.

Seizure. 2016 Oct;41:26-41. doi: 10.1016/j.seizure.2016.07.002. Epub 2016 Jul 15. Review.

Supplemental Content

Loading ...
Support Center